Advertisement

Topics

Study: Patients undergoing adalimumab therapy can monitor drug levels with finger prick

10:48 EDT 9 Aug 2017 | Healio

Patients with rheumatic disease who take adalimumab can successfully monitor drug levels in their bodies with a finger prick, according to a recently published study.“Easy home sampling at different time points will benefit patients and could help to prescribe biologics optimally,” Karien Bloem, PhD, from the Amsterdam Rheumatology and Immunology Center, said in a press release.

Original Article: Study: Patients undergoing adalimumab therapy can monitor drug levels with finger prick

NEXT ARTICLE

More From BioPortfolio on "Study: Patients undergoing adalimumab therapy can monitor drug levels with finger prick"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...